Global Aptamers Market to Reach USD 4.38 Billion by 2031 Amid Diagnostic and Therapeutic Innovation

[San Diego, 4th June 2025] – Clearview Market Insights (CVMI) projects that the global aptamers market will grow from USD 1.52 billion in 2024 to USD 4.38 billion by 2031, achieving a compound annual growth rate (CAGR) of 16.3 percent. This strong outlook is supported by accelerating adoption in diagnostics, the rise of nucleic-acid therapeutics, and technological breakthroughs in aptamer discovery and modification.

"Aptamers offer a next-generation alternative to antibodies across diagnostics, therapeutics, and biosensors,” said Dr. Nicole Haider, senior molecular biology analyst at CVMI. “With AI-driven SELEX, nanotechnology convergence, and biosafety-grade modifications, aptamers are stepping into the biotech mainstream."

Request Sample @ https://clearviewmarketinsights.com/report-details/global-aptamers-market/

Key Numbers

  • 2024 Market Value: USD 1.52 billion
  • 2031 Market Value: USD 4.38 billion
  • Seven-Year CAGR: 16.3 percent
  • DNA Aptamers Share (2024): 48%
  • North America Market Share: 44%

Market Drivers

  • Oncology and infectious disease diagnostics
  • Chemical versatility and low immunogenicity
  • Growth in AI and high-throughput aptamer screening
  • Strong research pipelines in targeted delivery and biosensors

Company Highlights

  • SomaLogic expanded proteomic applications to over 7,000 protein targets.
  • Base Pair Biotechnologies launched AI discovery tools for aptamer affinity profiling.
  • Aptamer Group formed alliances with cell therapy developers.
  • NeoVentures deployed aptamer-based rapid test kits in food safety and agriculture.

Regional Insights

  • North America: Leads in therapeutic R&D and diagnostics adoption.
  • Asia-Pacific: Fastest-growing region with rising investment in precision medicine.
  • Europe: Focused on academic collaborations and diagnostic biosensor validation.
  • LATAM & MEA: Opportunities emerging in food safety and portable diagnostics.

2024–2025 Milestones

Quarter

Event

Outcome

Q1 2024

Base Pair debuts AI SELEX tool

Shortens lead identification by 35%

Q2 2024

WHO trials aptamer diagnostics for dengue

Positive early results in 3 countries

Q3 2024

SomaLogic expands SOMAscan diagnostic use

Validated for cardiac biomarkers

Q1 2025

Aptamer Group signs CAR-T targeting partnership

Therapeutic aptamer market entry confirmed

 

 

 

 

For more insights, visit https://clearviewmarketinsights.com/

 

About Clearview Market Insights:

Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.

 

Media contact:

Bhavani K

Marketing and Sales Head

ClearView Market Insights

Mail: sales@clearviewmarketinsights.com

Phone: +1 917-993-7369

0
Sponsored
V
Search
Sponsored
V
Sponsored
V
Sponsored
V
Suggestions

Health
Autologous Cell Therapy Market Forecast: Investment Opportunities, Leading Players, and Regional Growth Projections
The global autologous cell therapy market is projected to experience remarkable growth in the...
By rohinishinde 0 1K
Other
UAE Chiller Market Trends 2025: Key Insights & 6.3%% CAGR Projection
UAE Chiller Market Overview: 2025-2030 Base Year: 2024 Historical Years:  2020–23...
By sonukumar 0 180
Education
Secrets to Thriving in Online Courses: Expert Tips for Success
Online education has revolutionized the academic experience, especially for working nurses...
By jon32 0 214
App and Website
Multipurpose WordPress Theme
Multipurpose WordPress Theme for your website Multipurpose WordPress Theme for your website
By Jyde 21 4K
Other
Child Car Safety Seat Market in Asia-Pacific: Expanding Consumer Awareness
The child car safety seat market in Asia-Pacific is witnessing rapid growth driven primarily by...
By Kajal434 0 336
Sponsored
V
Sponsored
V
Sponsored
V